UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049132
Receipt number R000055961
Scientific Title JP-SHINE study: Pediatric Idiopathic Nephrotic Syndrome Registry
Date of disclosure of the study information 2022/12/31
Last modified on 2023/08/03 08:15:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

JP-SHINE study: Pediatric Idiopathic Nephrotic Syndrome Registry

Acronym

JP-SHINE study: Pediatric Idiopathic Nephrotic Syndrome Registry

Scientific Title

JP-SHINE study: Pediatric Idiopathic Nephrotic Syndrome Registry

Scientific Title:Acronym

JP-SHINE study: Pediatric Idiopathic Nephrotic Syndrome Registry

Region

Japan


Condition

Condition

infantile idiopathic nephrotic syndrome

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

A registry will be established for patients with the intractable pediatric idiopathic nephrotic syndrome, and long-term observation will be conducted to clarify the actual treatment status and long-term prognosis of the disease.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of cases that progressed to refractory nephrotic syndrome as a percentage of total enrollment
Time to refractoriness

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Patients newly diagnosed with pediatric idiopathic nephrotic syndrome after approval by the Ethics Committee (including patients transferred to the hospital before (or during) the initial treatment)
(2) 999 patients enrolled in an existing study (JP-SHINE Study)
(3) Patients aged between 6 months and 15 years at the time of diagnosis

Key exclusion criteria

(i) Patients deemed inappropriate for this study by the physician in charge

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Kenji
Middle name
Last name Ishikura

Organization

Kitasato University

Division name

Faculty of Medicine

Zip code

252-0374

Address

1-15-1 Kitasato, Minami-ku, Sagamihara-shi, Kanagawa

TEL

042-778-8111

Email

info@pckd.jpn.org


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Kikunaga

Organization

Kitasato University

Division name

Faculty of Medicine

Zip code

252-0374

Address

1-15-1 Kitasato, Minami-ku, Sagamihara-shi, Kanagawa

TEL

042-778-8111

Homepage URL


Email

info@pckd.jpn.org


Sponsor or person

Institute

Ministry of Health, Labour and Welfare

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University

Address

1-15-1 Kitasato, Minami-ku, Sagamihara-shi, Kanagawa

Tel

042-778-8111

Email

info@pckd.jpn.org


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 08 Month 15 Day

Date of IRB

2023 Year 07 Month 27 Day

Anticipated trial start date

2023 Year 08 Month 03 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2022 Year 10 Month 06 Day

Last modified on

2023 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055961


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name